For Canadians suffering from chronic and terminal illnesses including severe pain, chronic inflammation due to arthritis or the nausea associated with chemotherapy, medical marijuana has
I received the following press release and figured it was worth passing along for discussion: The X-Change Corporation (NASDAQ OTC: XCHC), a U.S. Company specializing in cannabinoid formulation-based health
Several days ago I saw a news article about medical marijuana being legalized in France, and I eagerly clicked on the link only to learn
By Paul Armentano, NORML Deputy Director NSAIDs (non-steroidal anti-inflammatory drugs such as ibuprofren) are among the most widely used analgesic substances in the world. However,
By Doug Fine I missed out on an $8,000 one-day profit several weeks ago when I declined an opportunity to invest in British-based GW Pharmaceuticals,
Medbox, Inc. (OTC Markets: MDBX) (www.medboxinc.com), a leader in providing consulting services and patented systems to the medical and retail industries, announced that their MedVend
By TruthOnPot.Com It seems like one of the greatest fears of the medical marijuana community is slowly being realized, as corporations quickly adopt cannabinoids into
Latest Emails Show the Extent Of Obama’s Ties To The Pharmaceutical Industry On the campaign trail Barack ‘Blaze a Blunt’ Obama promised not to sell
The administration of a cannabinoid agonist is neuroprotective in subjects with cerebral ischemia (a condition characterized by insufficient blood flow to the brain resulting in
Here’s a great info-graphic describing how greedy prescription drug companies do what they can to keep us hooked on their products.
Cannabis Science, Inc. a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products, is pleased to share new photographs from this cancer patient with severe
By Steve Elliott of Toke of the Town Federal prosecutors in the Obama Administration are going after medical marijuana dispensaries. How are pharmaceutical companies involved?
By Barbara Venezia Those who believe they’re on the cutting edge of the medical marijuana bubble are passionate, and in some cases, quite controversial. One
Cannabis Science Reaches Final Partnership Structure with Unconventional Foundation for Autism (UF4A) Cannabis Science, Inc. , a pioneering US biotech company developing pharmaceutical cannabis products,
By Lanny Swerdlow, RN, LNC Next year, the patent on Marinol–the synthetic version of THC–comes to an end, opening the market for synthetic THC distribution
Medical Marijuana Inc is pleased to announce completion of a draft for a preliminary petition to the Federal Government to obtain a DEA sanctioned License
Doctors say refusal of PCTs to prescribe Sativex is causing “unnecessary suffering” By Denis Campbell The NHS has been criticised by doctors for denying multiple
By Jasen T. Davis Why there’s a plot to OK the sale of pharmaceutical cannabis–but keep the homegrown stuff illegal Right now, under federal law,
Health Science research involves exploring technologies and treatments that improve healthcare. Research involving medical cannabis is often passed over within this large industry. One company,
Converted Organics Inc. announced today that PharmaSphere Systems, LLC has entered into a Term Sheet and Memorandum of Understanding with Innovative Solutions for Non-Profits, Inc.
Marijuana, Inc. announced the pending application for a true cannabis derived remedy. Marijuana, Inc. intends to file a patent application as the owner of a
Cannabis Science, Inc., a pioneering US biotech company developing pharmaceutical cannabis products, has acquired 100% of a private company with two revenue producing operations, an
